Stuttgart - Delayed Quote EUR
Vitrolife AB (VTFN.SG)
13.24
-0.83
(-5.90%)
At close: April 25 at 8:09:44 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
3,610,000
3,609,000
3,512,000
3,234,000
1,681,000
Cost of Revenue
1,468,000
1,470,000
1,534,000
1,454,000
635,000
Gross Profit
2,141,000
2,139,000
1,977,000
1,780,000
1,046,000
Operating Expense
1,376,000
1,356,000
5,567,000
1,133,000
618,000
Operating Income
765,000
783,000
-3,590,000
647,000
428,000
Net Non Operating Interest Income Expense
-95,000
-109,000
-123,000
-58,000
-9,000
Pretax Income
672,000
674,000
-3,712,000
537,000
460,000
Tax Provision
173,000
160,000
139,000
143,000
116,000
Net Income Common Stockholders
498,000
513,000
-3,851,000
394,000
341,000
Diluted NI Available to Com Stockholders
498,000
513,000
-3,851,000
394,000
341,000
Basic EPS
3.68
--
-28.44
2.91
2.97
Diluted EPS
3.67
--
-28.44
2.91
2.97
Basic Average Shares
135,417.96
--
135,394.62
135,394.62
114,625.05
Diluted Average Shares
135,525.49
--
135,394.62
135,394.62
114,625.05
Total Operating Income as Reported
767,000
783,000
-3,589,000
654,000
435,000
Total Expenses
2,844,000
2,826,000
7,101,000
2,587,000
1,253,000
Net Income from Continuing & Discontinued Operation
498,000
513,000
-3,851,000
394,000
341,000
Normalized Income
498,000
513,000
-3,851,000
407,206.70
339,504.35
Interest Income
--
--
16,000
2,000
1,000
Interest Expense
--
--
94,000
44,000
10,000
Net Interest Income
-95,000
-109,000
-123,000
-58,000
-9,000
EBIT
765,000
783,000
-3,590,000
581,000
470,000
EBITDA
765,000
783,000
-3,590,000
977,000
579,000
Reconciled Cost of Revenue
1,468,000
1,470,000
1,534,000
1,454,000
635,000
Reconciled Depreciation
--
--
425,000
396,000
109,000
Net Income from Continuing Operation Net Minority Interest
498,000
513,000
-3,851,000
394,000
341,000
Total Unusual Items Excluding Goodwill
2,205
--
-4,303,000
-18,000
2,000
Total Unusual Items
2,205
--
-53,000
-18,000
2,000
Normalized EBITDA
765,000
783,000
-3,590,000
995,000
577,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
--
--
--
-4,793.30
504.35
12/31/2021 - 6/17/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade